Core Laboratories (CLB) Stock Statistics & Valuation Metrics
Total Valuation
Core Laboratories has a market cap or net worth of MXN 9.17B. The enterprise value is MXN 599.81M.
- Market Cap
- MXN 9.17B
- Enterprise Value
- MXN 599.81M
Share Statistics
Core Laboratories has 45,884,540 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 45,884,540
- Owned by Insiders
- 1.16%
- Owned by Institutions
- 54.67%
Financial Efficiency
Core Laboratories’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 6.83%.
- Return on Equity (ROE)
- 0.11
- Return on Assets (ROA)
- 0.05
- Return on Invested Capital (ROIC)
- 6.83%
- Return on Capital Employed (ROCE)
- 0.11
- Revenue Per Employee
- 159.55K
- Profits Per Employee
- 8,990.606
- Employee Count
- 3,300
- Asset Turnover
- 0.90
- Inventory Turnover
- 7.93
Valuation Ratios
The current PE Ratio of Core Laboratories is 31.29. Core Laboratories’s PEG ratio is -0.63.
- PE Ratio
- 31.29
- PS Ratio
- 0.94
- PB Ratio
- 1.79
- Price to FCF
- 23.37
- Price to Operating Cash Flow
- 20.13
- PEG Ratio
- -0.63
Income Statement
In the last 12 months, Core Laboratories had revenue of 526.52M and earned 29.67M in profits. Earnings per share was 0.68.
- Revenue
- 526.52M
- Gross Profit
- 94.28M
- Operating Income
- 50.49M
- Pretax Income
- 45.90M
- Net Income
- 29.67M
- EBITDA
- 71.12M
- Earnings Per Share (EPS)
- 0.68
Cash Flow
In the last 12 months, operating cash flow was 24.69M and capital expenditures -3.80M, giving a free cash flow of 20.89M billion.
- Operating Cash Flow
- 24.69M
- Free Cash Flow
- 20.89M
- Free Cash Flow per Share
- 0.45
Dividends & Yields
Core Laboratories pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 4.28%
- Earnings Yield
- 3.13%
Important Dates
Core Laboratories upcoming earnings date is Feb 03, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 28, 2026
- Next Earnings Date
- Feb 03, 2027
- Ex-Dividend Date
- ―
Financial Position
Core Laboratories as a current ratio of 2.02, with Debt / Equity ratio of 61.66%
- Current Ratio
- 2.02
- Quick Ratio
- 1.51
- Debt to Market Cap
- 0.15
- Net Debt to EBITDA
- 1.99
- Interest Coverage Ratio
- 4.78
Taxes
In the past 12 months, Core Laboratories has paid 15.51M in taxes.
- Income Tax
- 15.51M
- Effective Tax Rate
- 0.34
Enterprise Valuation
Core Laboratories EV to EBITDA ratio is 11.67, with an EV/FCF ratio of 30.10.
- EV to Sales
- 1.22
- EV to EBITDA
- 11.67
- EV to Free Cash Flow
- 30.10
- EV to Operating Cash Flow
- 25.47
Balance Sheet
Core Laboratories has MXN 21.38M in cash and marketable securities with MXN 161.97M in debt, giving a net cash position of -MXN 140.59M billion.
- Cash & Marketable Securities
- MXN 21.38M
- Total Debt
- MXN 161.97M
- Net Cash
- -MXN 140.59M
- Net Cash Per Share
- -MXN 3.06
- Tangible Book Value Per Share
- MXN 3.67
Margins
Gross margin is 17.67%, with operating margin of 7.57%, and net profit margin of 3.01%.
- Gross Margin
- 17.67%
- Operating Margin
- 7.57%
- Pretax Margin
- 5.38%
- Net Profit Margin
- 3.01%
- EBITDA Margin
- 10.43%
- EBIT Margin
- 7.52%
Analyst Forecast
The average price target for Core Laboratories is MXN 205.29, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
- Price Target
- MXN 205.29
- Price Target Upside
- ―
- Analyst Consensus
- Moderate Sell
- Analyst Count
- 1
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
Scores
- Smart Score
- 3
- AI Score
- ―
